Tolman Wiker
Pac Premier
Farmers merchants
You are here:  Home  >  Biotech  >  Current Article

Biotech firm Arcutis gets $94.5M in funding round

By   /   Monday, October 21st, 2019  /   No Comments

    Print       Email
Westlake Village dermatology therapy startup Arcutis announced a $94.5 million capital raise Oct. 21 to fund Phase 3 clinical development for its topical plaque psoriasis treatment. The financing round was led by HBM Healthcare Investments and included funding from Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures and Goldman Sachs. Returning investors also contributed to the…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

SCE reaches $360 million settlement with public agencies for wildfires, mudslides

Read More →